))
Ep. 35 - CBD, The Wonder Drug!
Manage episode 440997343 series 3546136
Contenu fourni par Dr. Denise Foster. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par Dr. Denise Foster ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.
Cannabidiol, or CBD, was discovered in 1940 by Dr. Roger Adams in a sample of hemp he was testing for intoxicating compounds. Prior to the discovery of THC in 1964, scientists were busy looking for the magic ingredient that caused all of the impairing effects of cannabis and happened upon CBD during their search. Fast forward to modern day research, where we now understand how CBD works in the body to create many beneficial physiological and psychological effects.
On this episode of CNT, we highlight the wonders of CBD, the miracle drug that seems to be able to affect numerous chronic conditions, including hypertension, cancer, neurodegenerative disease, and even COVID-19 infection. It can also prevent numerous conditions, such as autoimmune and psychological disorders. So, why isn't CBD part of your daily wellness regimen?
Episode Resources
Appendino, G. (2020). The early history of cannabinoid research. Cannabis and Cannabinoids, 31(4), 919–929. https://doi.org/10.1007/s12210-020-00956-0
Bhunia, S., Kolishetti, N., Arias, A.Y., Vashist, A., & Nair, M. (2022). Cannabidiol for neurodegenerative disorders: A comprehensive review. Frontiers in Pharmacology, 13. https://doi.org/10.3389/fphar.2022.989717
Britch, S.C., Babalonis, S., & Walsh, S.L. (2021). Cannabidiol: Pharmacology and Therapeutic Targets. Psychopharmacology, 238(1), 9–28. https://doi.org/10.1007/s00213-020-05712-8
Dujic, G., Kumric, M., Vrdoljak, J., Dujic, Z., & Bozic, J. (2024). Chronic Effects of Oral Cannabidiol Delivery on 24-h Ambulatory Blood Pressure in Patients with Hypertension (HYPER-H21-4): A Randomized, Placebo-Controlled, and Crossover Study. Cannabis and Cannabinoid Research, 9(4), 979–989. https://doi.org/10.1089/can.2022.0320
Esposito, G., Pesce, M., Seguella, L., Sanseverino, W., Lu, J., Corpetti, C., & Sarnelli, G. (2020). The potential of cannabidiol in the COVID-19 pandemic. British Journal of Pharmacology, 177(21), 4967–4970. https://doi.org/10.1111/bph.15157
Mabou Tagne, A., Pacchetti, B., Sodergren, M., Cosentino, M., & Marino, F. (2020). Cannabidiol for Viral Diseases: Hype or Hope? Cannabis and Cannabinoid Research, 5(2), 121–131. https://doi.org/10.1089/can.2019.0060
Nguyen, L.C., Yang, D., Nicolaescu, V., Best, T.J., Gula, H., Saxena, D., Gabbard, J.D., Chen, S.-N., Ohtsuki, T., Friesen, J. B., Drayman, N., Mohamed, A., Dann, C., Silva, D., Robinson-Mailman, L., Valdespino, A., Stock, L., Suárez, E., Jones, K.A., … Rosner, M.R. (2022). Cannabidiol inhibits SARS-CoV-2 replication through induction of the host ER stress and innate immune responses. Science Advances, 8(8), eabi6110. https://doi.org/10.1126/sciadv.abi6110
Peng, J., Fan, M., An, C., Ni, F., Huang, W., & Luo, J. (2022). A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD). Basic & Clinical Pharmacology & Toxicology, 130(4), 439–456. https://doi.org/10.1111/bcpt.13710
Seltzer, E.S., Watters, A.K., MacKenzie, D., Granat, L.M., & Zhang, D. (2020). Cannabidiol (CBD) as a Promising Anti-Cancer Drug. Cancers, 12(11), Article 11. https://doi.org/10.3390/cancers12113203
40 episodes
Partager
